Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAllarity Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $1.00 at 04:47 AM on Sep 21, then ran to $1.20 +20% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is ALLR up today? It is at $1.01 (+2.51%), and our scanner flagged it 7 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ALLR spikes, and full due diligence on ALLR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ALLR 7 times in the last 30 days. Create a free account to track $ALLR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ALLR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ALLR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Ervin Jeffrey S Officer | Acquired (grant/award) | +150K 0.9% of company | n/a | 150K | n/a | Jan 28, 26 |
Mclaughlin Gerald W. Director | Acquired (grant/award) | +45K 0.3% of company | added 100% | 70K | n/a | Jan 28, 26 |
Jensen Thomas Officer | Acquired (grant/award) | +200K 1.3% of company | added 50% | 597K | n/a | Jan 28, 26 |
Graff Jeremy R. Officer | Acquired (grant/award) | +133K 0.8% of company | added 54% | 382K | n/a | Jan 7, 26 |
Hoeiland Jesper Director | Acquired (grant/award) | +25K 0.2% of company | n/a | 25K | n/a | Jan 7, 26 |
Graff Jeremy R. Officer | Sold (automatic/other) | -15K 0.09% of company | sold 37% | 25K | $23K at $1.58 | Sep 30, 25 |
Graff Jeremy R. Officer | Other | 39K 0.2% of company | n/a | 39K | n/a | Sep 30, 25 |
Jensen Thomas Officer | Acquired (grant/award) | +397K 2.5% of company | n/a | 397K | n/a | Jan 22, 25 |
Epshinsky Alexander Officer | Acquired (grant/award) | +29K 0.2% of company | added 53% | 85K | n/a | Jan 22, 25 |
Graff Jeremy R. Officer | Acquired (grant/award) | +144K 0.9% of company | added 100% | 263K | n/a | Jan 22, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ALLR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ALLR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ALLR last traded at $1.01, up 2.51% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Allarity Therapeutics, Inc. Common Stock (ALLR) is next expected to report earnings on Friday, November 13, 2026, about 37 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ALLR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ALLR 7 times in the last 30 days.
ALLR (Allarity Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $16M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ALLR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ALLR discussion
Sign in to ask a question or join the discussion.